193 related articles for article (PubMed ID: 8903337)
1. In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.
Yudkoff M; Daikhin Y; Nissim I; Jawad A; Wilson J; Batshaw M
J Clin Invest; 1996 Nov; 98(9):2167-73. PubMed ID: 8903337
[TBL] [Abstract][Full Text] [Related]
2. Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.
Marini JC; Lanpher BC; Scaglia F; O'Brien WE; Sun Q; Garlick PJ; Jahoor F; Lee B
Am J Clin Nutr; 2011 Jun; 93(6):1248-54. PubMed ID: 21490144
[TBL] [Abstract][Full Text] [Related]
3. In vivo measurement of ureagenesis with stable isotopes.
Yudkoff M; Daikhin Y; Ye X; Wilson JM; Batshaw ML
J Inherit Metab Dis; 1998; 21 Suppl 1():21-9. PubMed ID: 9686342
[TBL] [Abstract][Full Text] [Related]
4. Differential utilization of systemic and enteral ammonia for urea synthesis in control subjects and ornithine transcarbamylase deficiency carriers.
Scaglia F; Marini J; Rosenberger J; Henry J; Garlick P; Lee B; Reeds P
Am J Clin Nutr; 2003 Oct; 78(4):749-55. PubMed ID: 14522733
[TBL] [Abstract][Full Text] [Related]
5. Correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency.
Batshaw ML; Robinson MB; Ye X; Pabin C; Daikhin Y; Burton BK; Wilson JM; Yudkoff M
Pediatr Res; 1999 Nov; 46(5):588-93. PubMed ID: 10541323
[TBL] [Abstract][Full Text] [Related]
6. An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency.
Scaglia F; Zheng Q; O'Brien WE; Henry J; Rosenberger J; Reeds P; Lee B
Pediatrics; 2002 Jan; 109(1):150-2. PubMed ID: 11773558
[TBL] [Abstract][Full Text] [Related]
7. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency.
Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW
Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency.
Nagasaka H; Yorifuji T; Egawa H; Inui A; Fujisawa T; Komatsu H; Tsukahara H; Uemoto S; Inomata Y
Mol Genet Metab; 2013 Jul; 109(3):251-4. PubMed ID: 23669167
[TBL] [Abstract][Full Text] [Related]
9. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V
Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167
[TBL] [Abstract][Full Text] [Related]
10. Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency.
Brusilow SW; Finkelstien J
Metabolism; 1993 Oct; 42(10):1336-9. PubMed ID: 8412748
[TBL] [Abstract][Full Text] [Related]
11. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
Scaglia F; Carter S; O'Brien WE; Lee B
Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
[TBL] [Abstract][Full Text] [Related]
12. In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle.
Lee B; Yu H; Jahoor F; O'Brien W; Beaudet AL; Reeds P
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8021-6. PubMed ID: 10869432
[TBL] [Abstract][Full Text] [Related]
13. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of phenylbutyrate metabolites by UPLC-MS/MS demonstrates inverse correlation of phenylacetate:phenylacetylglutamine ratio with plasma glutamine levels.
Jiang Y; Almannai M; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2017 Nov; 122(3):39-45. PubMed ID: 28888854
[TBL] [Abstract][Full Text] [Related]
15. Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis.
Brusilow SW
J Clin Invest; 1984 Dec; 74(6):2144-8. PubMed ID: 6511918
[TBL] [Abstract][Full Text] [Related]
16. Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database.
Sen K; Izem R; Long Y; Jiang J; Konczal LL; McCarter RJ; ; Gropman AL; Bedoyan JK
Mol Genet Genomic Med; 2024 Apr; 12(4):e2443. PubMed ID: 38634223
[TBL] [Abstract][Full Text] [Related]
17. Ornithine restores ureagenesis capacity and mitigates hyperammonemia in Otc(spf-ash) mice.
Marini JC; Lee B; Garlick PJ
J Nutr; 2006 Jul; 136(7):1834-8. PubMed ID: 16772445
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of girls with ornithine transcarbamylase deficiency.
Maestri NE; Brusilow SW; Clissold DB; Bassett SS
N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
[TBL] [Abstract][Full Text] [Related]
19. Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency.
Belanger AJ; Gefteas E; Przybylska M; Geller S; Anarat-Cappillino G; Kloss A; Yew NS
J Inherit Metab Dis; 2023 Jan; 46(1):55-65. PubMed ID: 36220785
[TBL] [Abstract][Full Text] [Related]
20. In vivo monitoring of urea cycle activity with (13)C-acetate as a tracer of ureagenesis.
Opladen T; Lindner M; Das AM; Marquardt T; Khan A; Emre SH; Burton BK; Barshop BA; Böhm T; Meyburg J; Zangerl K; Mayorandan S; Burgard P; Dürr UH; Rosenkranz B; Rennecke J; Derbinski J; Yudkoff M; Hoffmann GF
Mol Genet Metab; 2016 Jan; 117(1):19-26. PubMed ID: 26597322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
